Showing results (41-50 of 309) with videos related to
Sort By:
Pageof 31
Psychological Medicine|June 17, 1998
The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patientsE Schweizer, K Rickels, N De Martinis, et al.Journal of Clinical Psychopharmacology|April 22, 1999
Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuationK Rickels, I Lucki, E Schweizer, et al.The Journal of Clinical Psychiatry|January 1, 1995
Nefazodone: aspects of efficacyK Rickels, D S Robinson, E Schweizer, et al.Pharmacopsychiatry|March 1, 1990
Lorazepam vs. alprazolam in the treatment of panic disorderE Schweizer, R Pohl, R Balon, et al.The Journal of Clinical Psychiatry|January 1, 1990
What constitutes an adequate antidepressant trial for fluoxetine?E Schweizer, K Rickels, J D Amsterdam, et al.Psychopharmacology|February 1, 1995
Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcomeE Schweizer, W G Case, F Garcia-Espana, et al.Psychopharmacology|February 10, 1999
Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcomeK Rickels, E Schweizer, F Garcia España, et al.International Clinical Psychopharmacology|May 17, 2001
The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trialE Schweizer, M Rynn, L A Mandos, et al.Psychopharmacology Bulletin|January 1, 1990
Buspirone in depressed outpatients: a controlled studyK Rickels, J Amsterdam, C Clary, et al.International Clinical Psychopharmacology|November 1, 1995
Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorderL A Mandos, K Rickels, N Cutler, et al.Pageof 31